A Review of Designing New Vaccines to Prevent Hospital- Acquired Antibiotic-Resistant Infections
- سال انتشار: 1398
- محل انتشار: مجله بیماری و تشخیص، دوره: 7، شماره: 2
- کد COI اختصاصی: JR_IEJM-7-2_004
- زبان مقاله: انگلیسی
- تعداد مشاهده: 428
نویسندگان
Department of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
Department of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
چکیده
Hospital-acquired infections are one of the main challenges and concerns of patients and medical staff in hospitals and healthcare centers. Meanwhile, Clostridium difficile infection is one of the most important bacterial hospital infections. Prevention is the best and most effective way to deal with these infections. Designing and using vaccines against these infectious microorganisms is the best way of prevention. In this review, we evaluated 80 research articles and guidelines in the field of designing and developing new vaccines against nosocomial infections. The articles were collected from Google Scholar, PubMed, Research Gate, NCBI, CDC, and WHO databases. To date, considering the properties and virulence factors of each microorganism, some vaccines have been designed and made up from cellular complexes or recombinant proteins. The magnitude of vaccine effect varies by bacteria and strain type. Some vaccines have conferred high-levels of protection and immunity. However, there is still no vaccine against some bacteria, which has led to more in-depth research in this area. Although significant successful attempts have been made so far to design vaccines against the most important hospital-acquired infections, there is still a essential need to design and develop new vaccines against these infectious bacteriaکلیدواژه ها
Hospital-Acquired Infection, Vaccine, Clostridium difficile, Methicillin-Resistant Staphylococcus aureus, Acinetobacter baumanniiمقالات مرتبط جدید
- چالش های برخی گیاهان دارویی استان کهگیلویه و بویراحمد
- Evaluation of Candida auris Colonization using Clinical Skin Swabs: A Single-Center Study in Isfahan, Iran
- Support and Practice of Smoke-Free Eating Places in Sarawak, Malaysia: A Structural Path Analysis
- Rate and Causes of Claim Denials in Iranian Hospitals: A Systematic Review and Meta-analysis
- The Effect of Impulsivity on Addition and Addictive Tendencies: A Meta-analysis
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.